Start Over

Prenatal exome sequencing in fetuses with callosal anomalies.

Authors :: Lei TY
She Q
Fu F
Zhen L
Li R
Yu QX
Wang D
Li YS
Cheng K
Zhou H
Yang X
Pan M
Li DZ
Liao C
Source :: Prenatal diagnosis [Prenat Diagn] 2022 May; Vol. 42 (6), pp. 744-752. Date of Electronic Publication: 2022 Feb 04.
Publication Year :: 2022
Abstract: Objective: We aimed to investigate the value of exome sequencing (ES) in fetuses with callosal anomalies (CA) with or without other structural anomalies, but with normal findings by karyotyping and chromosome microarray analysis (CMA).<br />Methods: Cases with CA with or without other structural anomalies were screened for eligibility. Fetuses with abnormal karyotyping or CMA results were excluded. We performed ES on DNA samples from eligible fetus-parental trios and identified diagnostic genetic variants based on the ultrasonographic features.<br />Results: A total of 50 eligible fetus-parental trios were successfully analyzed by ES. We found 17 likely pathogenic or pathogenic variants in 14 genes from 17 fetuses, with a total proportion of diagnostic genetic variants equal to 34.0% (17/50). Of the 17 cases with a diagnosis, 10 (29.4%, 10/35) were isolated and 7 (43.8%, 7/15) were non-isolated. Pregnancy outcome data showed that 70.0% (7/10) of the surviving isolated CA fetuses with negative ES results had a good prognosis in early childhood.<br />Conclusions: Our study used ES prenatally for CA and showed that ES can be used diagnostically to define the molecular defects that underlie unexplained CA. Most subjects with isolated CA with negative results for genetic causes will have a favorable prognosis in early childhood.<br /> (© 2022 John Wiley & Sons Ltd.)